Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ENGN


Fundamental

Company: enGene Holdings Inc
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Exchange: NASD
Index: -
P/E: -
EPS (ttm): -1.65
Insider Own: 57.16%
Shs Outstand: 51.07M
Perf Week: -2.99%
Market Cap: 166.09M
Forward P/E: -
EPS next Y: -2.22
Insider Trans: 0.00%
Shs Float: 21.89M
Perf Month: -4.41%
Income: -79.88M
PEG: -
EPS next Q: -0.50
Inst Own: 41.04%
Short Float: 0.18%
Perf Quarter: -36.65%
Sales: 0.00M
P/S: -
EPS this Y: -37.37%
Inst Trans: -26.67%
Short Ratio: 0.57
Perf Half Y: -56.67%
Book/sh: 4.45
P/B: 0.73
EPS next Y Percentage: -10.90%
ROA: -29.57%
Short Interest: 0.04M
Perf Year: -67.17%
Cash/sh: 4.26
P/C: 0.76
EPS next 5Y: -9.10%
ROE: -33.97%
52W Range From: 2.65
52W Range To: 11.00
Perf YTD: -51.13%
Dividend Est.: -
P/FCF: -
EPS past 5Y: -
ROIC: -32.12%
52W High: -70.45%
Beta: -0.39
Dividend TTM: -
Quick Ratio: 12.66
Sales past 5Y: -
Gross Margin: -
52W Low: 22.64%
ATR (14): 0.45
Dividend Ex-Date: Aug 03, 2015
Current Ratio: 12.66
EPS Y/Y TTM: 69.23%
Oper. Margin: -
RSI (14): 39.59
Volatility W: 2.89%
Volatility M: 5.87%
Employees: 57
Debt/Eq: 0.11
Sales Y/Y TTM: -
Profit Margin: -
Recom: 1.27
Target Price: 22.45
Option/Short: No / Yes
LT Debt/Eq: 0.09
EPS Q/Q: -33.19%
Payout: -
Rel Volume: 1.99
Prev Close: 3.33
Sales Surprise: -
EPS Surprise: -2.55%
Sales Q/Q: -
Earnings: Jun 12 BMO
Avg Volume: 68.93K
Price: 3.25
SMA20: -13.90%
SMA50: -14.23%
SMA200: -46.91%
Trades:
Volume: 80,721
Change: -2.40%

Technical:


Latest News:

Wells Fargo & Company Initiates Coverage on enGene (NASDAQ:ENGN) - Defense World somewhat bullish
ENGN

Summary: Wells Fargo & Company initiated coverage on enGene (NASDAQ:ENGN) with an overweight rating and a $30.00 price target. Several other research firms have also given positive ratings and price targets on the stock. Insiders recently sold shares of enGene. Institutional investors have been actively acquiring stakes in the company.

Full article
2024-04-23T13:50:50Z
Wells Fargo Initiates Coverage of enGene Holdings (ENGN) with Overweight Recommendation very bullish
ENGN

Summary: Wells Fargo initiated coverage of enGene Holdings (NasdaqCM:ENGN) with an Overweight recommendation, projecting a 145.66% upside based on the average one-year price target of $36.21. Various major shareholders hold significant ownership stakes in the company.

Full article
2024-04-22T22:24:28Z